Replies to post #252537 on Biotech Values

[DewDiligence]

RSLS—>HIND at Friday’s open, following 1:4 reverse split, pursuant to previously announced reverse-merger:

https://www.businesswire.com/news/home/20250813072681/en/Vyome-Announces-Nasdaq-Approval-of-Merger-with-ReShape-Lifesciences-Set-to-Begin-Trading-as-HIND